Literature DB >> 16648518

Statins and breast cancer prevention: time for randomized controlled trials.

Julian R Sprague, Marie E Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16648518     DOI： 10.1200/JCO.2005.05.5392

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.

Authors:  YongLi Ji; Tiffany Rounds; Abigail Crocker; Betsy Sussman; Russell C Hovey; Fonda Kingsley; Hyman B Muss; Judy E Garber; Marie E Wood
Journal:  Cancer Prev Res (Phila)       Date:  2016-02-23

2.  Statin use and breast cancer risk in a large population-based setting.

Authors:  Denise M Boudreau; Onchee Yu; Diana L Miglioretti; Diana S M Buist; Susan R Heckbert; Janet R Daling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

Review 3.  Statins and breast cancer prognosis: evidence and opportunities.

Authors:  Thomas P Ahern; Timothy L Lash; Per Damkier; Peer M Christiansen; Deirdre P Cronin-Fenton
Journal:  Lancet Oncol       Date:  2014-09       Impact factor: 41.316

Review 4.  Statin use and cancer risk: a comprehensive review.

Authors:  Denise M Boudreau; Onchee Yu; Jeanene Johnson
Journal:  Expert Opin Drug Saf       Date:  2010-07       Impact factor: 4.250

5.  Statin use and prostate cancer risk in a large population-based setting.

Authors:  Denise M Boudreau; Onchee Yu; Diana S M Buist; Diana L Miglioretti
Journal:  Cancer Causes Control       Date:  2008-03-06       Impact factor: 2.506

Review 6.  Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.

Authors:  Natalia A Riobo-Del Galdo; Ángela Lara Montero; Eva V Wertheimer
Journal:  Cells       Date:  2019-04-25       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.